ADAG
Adagene, Inc.
NASDAQ · Healthcare · Biotechnology · CN
$3.31
−1.78%Sep 10, 2026, 12:00 UTC
Third Arc Bio selected its first lead candidate under an amended strategic collaboration with Adagene for the development of masked CD3 T cell engagers utilizing Adagene's SAFEbody technology.
Source: